title: Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
abstract: Panretinal photocoagulation (PRP) reduces the incidence of severe visual loss in proliferative diabetic retinopathy (PDR). The aim of the study was to determine the effect of PRP on the activity of matrix metalloproteinase-2 (MMP-2) and MMP-9, and also on the alpha(2)-Macroglobulin (alpha(2)M) proteolytic state in the vitreous of eyes with PDR. Vitreous samples were obtained from patients undergoing vitrectomy for the treatment of retinal diseases: 17 with PDR and eight with idiopathic macular hole (MH). Qualitative evaluation of the MMP-2 and MMP-9 activation status was performed by gelatin zymography and quantitative assay was carried out for vitreous total protein content and alpha(2)M. The proteolytic state of alpha(2)M was evaluated by Western blotting. Although all vitreous samples contained proMMP-2, increased proMMP-9 and active MMP-9 were detected in PDR samples without PRP. In addition, after PRP the proMMP-9 activity was significantly decreased, whereas the proMMP-2 activity was not affected. Enhanced total protein and alpha(2)M concentrations were observed in all vitreous samples from PDR patients with and without previous PRP compared with samples from patients with MH. However, a differential proteolytic state of alpha(2)M, expressed as 180/85-90kDa ratio, was detected among PDR patients with and without PRP treatment. Whereas a low 180/85-90kDa ratio of alpha(2)M in vitreous of PDR patients without PRP was observed, a high proportion of 180kDa subunit was principally detected in PDR with PRP. These results demonstrate that PDR occurs with an enhanced activity of MMP-9 and activation of alpha(2)M by proteinases, which is reversed after PRP. In addition, we suggest that alpha(2)M plays a key role in the control and regulation of the ocular neovascularization involved in the pathogenesis of ischemic retinal diseases such as PDR.
authors.affiliation: Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET)-Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, Córdoba, Argentina. csanchez@bioclin.fcq.unc.edu.ar
authors.forename: María C
authors.initials: MC
authors.lastname: Sánchez
authors.forename: Jose D
authors.initials: JD
authors.lastname: Luna
authors.forename: Pablo F
authors.initials: PF
authors.lastname: Barcelona
authors.forename: Ana L
authors.initials: AL
authors.lastname: Gramajo
authors.forename: Patricio C
authors.initials: PC
authors.lastname: Juarez
authors.forename: Clelia M
authors.initials: CM
authors.lastname: Riera
authors.forename: Gustavo A
authors.initials: GA
authors.lastname: Chiabrando
mesh_terms: D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism; D003930:Diabetic Retinopathy / Q000201:enzymology / Q000378:metabolism / Q000601:surgery*; D005136:Eye Proteins / Q000378:metabolism; D005260:Female; D006801:Humans; D017075:Laser Coagulation; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D045726:Metalloproteases / Q000378:metabolism*; D008875:Middle Aged; D011184:Postoperative Period; D012167:Retinal Perforations / Q000201:enzymology / Q000378:metabolism; D014821:Vitrectomy; D014822:Vitreous Body / Q000201:enzymology / Q000378:metabolism*; D000511:alpha-Macroglobulins / Q000378:metabolism*